{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:07:55Z","timestamp":1784214475000,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04246-3","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T09:59:26Z","timestamp":1748512766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of combined BCG and SARS-CoV-2 vaccination for immune enhancement and lung protection in Syrian hamsters"],"prefix":"10.1038","volume":"15","author":[{"given":"Abbas","family":"Ashtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-4667","authenticated-orcid":false,"given":"Bahar","family":"Nayeri Fasaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehdi","family":"Joghataei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Dabaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Mosavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Eslampanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayyoob","family":"Arpanaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"4246_CR1","doi-asserted-by":"publisher","unstructured":"Gao, J. et al. Immunomics in one health: Understanding the human, animal, and environmental aspects of COVID-19. Front. Immunol. 15 https:\/\/doi.org\/10.3389\/fimmu.2024.1450380 (2024).","DOI":"10.3389\/fimmu.2024.1450380"},{"key":"4246_CR2","doi-asserted-by":"publisher","first-page":"e00103","DOI":"10.1128\/cmr.00103-22","volume":"37","author":"D Parkins Michael","year":"2023","unstructured":"Parkins Michael, D. et al. Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond. Clin. Microbiol. Rev. 37, e00103\u201300122. https:\/\/doi.org\/10.1128\/cmr.00103-22 (2023).","journal-title":"Clin. Microbiol. Rev."},{"key":"4246_CR3","doi-asserted-by":"crossref","unstructured":"Chang-Rabley, E., van Zelm, M. C., Ricotta, E. E. & Edwards, E. S. J. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity. Vaccines 12 (2024).","DOI":"10.3390\/vaccines12060675"},{"key":"4246_CR4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","volume":"6","author":"J Wei","year":"2021","unstructured":"Wei, J. et al. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the united Kingdom. Nat. Microbiol. 6, 1140\u20131149. https:\/\/doi.org\/10.1038\/s41564-021-00947-3 (2021).","journal-title":"Nat. Microbiol."},{"key":"4246_CR5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/annrheumdis-2021-220461","volume":"80","author":"D Simon","year":"2021","unstructured":"Simon, D. et al. SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann. Rheum. Dis. 80, 1312. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220461 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"4246_CR6","doi-asserted-by":"publisher","first-page":"e065306","DOI":"10.1136\/bmjopen-2022-065306","volume":"13","author":"M Aggarwal","year":"2023","unstructured":"Aggarwal, M. et al. What is the role of primary care in the COVID-19 vaccine roll-out and the barriers and facilitators to an equitable vaccine roll-out? A rapid scoping review of nine jurisdictions. BMJ Open. 13, e065306. https:\/\/doi.org\/10.1136\/bmjopen-2022-065306 (2023).","journal-title":"BMJ Open."},{"key":"4246_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41541-021-00406-4","volume":"6","author":"C Counoupas","year":"2021","unstructured":"Counoupas, C. et al. A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection. Npj Vaccines. 6, 143. https:\/\/doi.org\/10.1038\/s41541-021-00406-4 (2021).","journal-title":"Npj Vaccines"},{"key":"4246_CR8","doi-asserted-by":"publisher","first-page":"pbae015","DOI":"10.1093\/pcmedi\/pbae015","volume":"7","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. COVID-19: from immune response to clinical intervention. Precision Clin. Med. 7, pbae015. https:\/\/doi.org\/10.1093\/pcmedi\/pbae015 (2024).","journal-title":"Precision Clin. Med."},{"key":"4246_CR9","doi-asserted-by":"publisher","unstructured":"Gonzalez-Perez, M., Sanchez-Tarjuelo, R., Shor, B., Nistal-Villan, E. & Ochando, J. The BCG vaccine for COVID-19: first verdict and future directions. Front. Immunol. 12 https:\/\/doi.org\/10.3389\/fimmu.2021.632478 (2021).","DOI":"10.3389\/fimmu.2021.632478"},{"key":"4246_CR10","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s41564-023-01503-x","volume":"8","author":"EC Larson","year":"2023","unstructured":"Larson, E. C. et al. Intravenous Bacille Calmette\u2013Gu\u00e9rin vaccination protects Simian immunodeficiency virus-infected macaques from tuberculosis. Nat. Microbiol. 8, 2080\u20132092. https:\/\/doi.org\/10.1038\/s41564-023-01503-x (2023).","journal-title":"Nat. Microbiol."},{"key":"4246_CR11","doi-asserted-by":"publisher","first-page":"126203","DOI":"10.1016\/j.vaccine.2024.126203","volume":"42","author":"MA Ram\u00edrez","year":"2024","unstructured":"Ram\u00edrez, M. A. et al. Co-administration of Recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity. Vaccine 42, 126203. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126203 (2024).","journal-title":"Vaccine"},{"key":"4246_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ijtb.2023.05.012","volume":"70","author":"P Khandelia","year":"2023","unstructured":"Khandelia, P., Yadav, S. & Singh, P. An overview of the BCG vaccine and its future scope. Indian J. Tuberculosis. 70, S14\u2013S23. https:\/\/doi.org\/10.1016\/j.ijtb.2023.05.012 (2023).","journal-title":"Indian J. Tuberculosis"},{"key":"4246_CR13","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","volume":"22","author":"EB Irvine","year":"2021","unstructured":"Irvine, E. B. et al. Robust IgM responses following intravenous vaccination with Bacille Calmette\u2013Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques. Nat. Immunol. 22, 1515\u20131523. https:\/\/doi.org\/10.1038\/s41590-021-01066-1 (2021).","journal-title":"Nat. Immunol."},{"key":"4246_CR14","doi-asserted-by":"crossref","unstructured":"Koster, K. J., Webb, H. L. & Cirillo, J. D. COVID-19 and beyond: exploring public health benefits from Non-Specific effects of BCG vaccination. Microorganisms 9 (2021).","DOI":"10.3390\/microorganisms9102120"},{"key":"4246_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.trivac.2014.08.002","volume":"3","author":"N Talat Iqbal","year":"2014","unstructured":"Talat Iqbal, N. & Hussain, R. Non-specific immunity of BCG vaccine: A perspective of BCG immunotherapy. Trials Vaccinol. 3, 143\u2013149. https:\/\/doi.org\/10.1016\/j.trivac.2014.08.002 (2014).","journal-title":"Trials Vaccinol."},{"key":"4246_CR16","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1038\/s41598-021-87731-9","volume":"11","author":"W Fu","year":"2021","unstructured":"Fu, W. et al. Reconcile the debate over protective effects of BCG vaccine against COVID-19. Sci. Rep. 11, 8356. https:\/\/doi.org\/10.1038\/s41598-021-87731-9 (2021).","journal-title":"Sci. Rep."},{"key":"4246_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","volume":"183","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Activate: randomized clinical trial of BCG vaccination against infection in the elderly. Cell 183, 315\u2013323e319. https:\/\/doi.org\/10.1016\/j.cell.2020.08.051 (2020).","journal-title":"Cell"},{"key":"4246_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. BCG-induced trained immunity: history, mechanisms and potential applications. J. Translational Med. 21, 106. https:\/\/doi.org\/10.1186\/s12967-023-03944-8 (2023).","journal-title":"J. Translational Med."},{"key":"4246_CR19","doi-asserted-by":"publisher","unstructured":"Covi\u00e1n, C. et al. BCG-Induced Cross-Protection and development of trained immunity: implication for vaccine design. Front. Immunol. 10 https:\/\/doi.org\/10.3389\/fimmu.2019.02806 (2019).","DOI":"10.3389\/fimmu.2019.02806"},{"key":"4246_CR20","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41467-023-39096-y","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Vaccine-induced protection against SARS-CoV-2 requires IFN-\u03b3-driven cellular immune response. Nat. Commun. 14, 3440. https:\/\/doi.org\/10.1038\/s41467-023-39096-y (2023).","journal-title":"Nat. Commun."},{"key":"4246_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1389557522666220104152634","volume":"22","author":"KCM Borges","year":"2022","unstructured":"Borges, K. C. M. et al. BCG vaccination, and COVID-19: are they connected?? Mini Rev. Med. Chem. 22, 1631\u20131647. https:\/\/doi.org\/10.2174\/1389557522666220104152634 (2022). Tuberculosis.","journal-title":"Mini Rev. Med. Chem."},{"key":"4246_CR22","doi-asserted-by":"publisher","unstructured":"Upton, C. M. et al. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. eClinicalMedicine 48 https:\/\/doi.org\/10.1016\/j.eclinm.2022.101414 (2022).","DOI":"10.1016\/j.eclinm.2022.101414"},{"key":"4246_CR23","unstructured":"Akkiz, H. in PreprintsPreprints, (2024)."},{"key":"4246_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O\u2019Neill","year":"2020","unstructured":"O\u2019Neill, L. A. J. & Netea, M. G. BCG-induced trained immunity: can it offer protection against COVID-19? Nat. Rev. Immunol. 20, 335\u2013337. https:\/\/doi.org\/10.1038\/s41577-020-0337-y (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"4246_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3389\/fimmu.2019.02329","volume":"10","author":"J Miao","year":"2019","unstructured":"Miao, J., Chard, L. S., Wang, Z. & Wang, Y. Syrian Hamster as an animal model for the study on infectious diseases. Front. Immunol. 10, 2329. https:\/\/doi.org\/10.3389\/fimmu.2019.02329 (2019).","journal-title":"Front. Immunol."},{"key":"4246_CR26","doi-asserted-by":"crossref","unstructured":"Castellan, M. et al. Host response of Syrian Hamster to SARS-CoV-2 infection including differences with humans and between sexes. Viruses 15 (2023).","DOI":"10.3390\/v15020428"},{"key":"4246_CR27","doi-asserted-by":"publisher","first-page":"30541","DOI":"10.1038\/s41598-024-80498-9","volume":"14","author":"S Schirm","year":"2024","unstructured":"Schirm, S. et al. A biomathematical model of SARS-CoV-2 in Syrian hamsters. Sci. Rep. 14, 30541. https:\/\/doi.org\/10.1038\/s41598-024-80498-9 (2024).","journal-title":"Sci. Rep."},{"key":"4246_CR28","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath, J. C. & Lilley, E. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br. J. Pharmacol. 172, 3189\u20133193. https:\/\/doi.org\/10.1111\/bph.12955 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"4246_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ilar\/ily024","volume":"60","author":"K Bayne","year":"2019","unstructured":"Bayne, K. & Turner, P. V. Animal welfare standards and international collaborations. ILAR J. 60, 86\u201394. https:\/\/doi.org\/10.1093\/ilar\/ily024 (2019).","journal-title":"ILAR J."},{"key":"4246_CR30","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1038\/s41596-021-00536-y","volume":"16","author":"KR Bewley","year":"2021","unstructured":"Bewley, K. R. et al. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays. Nat. Protoc. 16, 3114\u20133140. https:\/\/doi.org\/10.1038\/s41596-021-00536-y (2021).","journal-title":"Nat. Protoc."},{"key":"4246_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.18502\/ijm.v14i3.9758","volume":"14","author":"MI Zapata-Cardona","year":"2022","unstructured":"Zapata-Cardona, M. I. et al. Comparison among plaque assay, tissue culture infectious dose (TCID(50)) and real-time RT-PCR for SARS-CoV-2 variants quantification. Iran. J. Microbiol. 14, 291\u2013299. https:\/\/doi.org\/10.18502\/ijm.v14i3.9758 (2022).","journal-title":"Iran. J. Microbiol."},{"key":"4246_CR32","doi-asserted-by":"publisher","unstructured":"Chan, J. F. et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp\/Hel Real-Time reverse Transcription-PCR assay validated in vitro and with clinical specimens. J. Clin. Microbiol. 58 https:\/\/doi.org\/10.1128\/jcm.00310-20 (2020).","DOI":"10.1128\/jcm.00310-20"},{"key":"4246_CR33","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1128\/jcm.01224-15","volume":"53","author":"JF Chan","year":"2015","unstructured":"Chan, J. F. et al. Development and evaluation of novel Real-Time reverse Transcription-PCR assays with locked nucleic acid probes targeting leader sequences of Human-Pathogenic coronaviruses. J. Clin. Microbiol. 53, 2722\u20132726. https:\/\/doi.org\/10.1128\/jcm.01224-15 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"4246_CR34","unstructured":"Bullen, C. K., Davis, S. L. & Looney, M. M. in SARS-CoV-2: Methods and Protocols (eds Justin Jang Hann Chu, Bintou Ahmadou Ahidjo, & Chee Keng Mok) 131\u2013146Springer US, (2022)."},{"key":"4246_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","volume":"36","author":"C Lei","year":"2021","unstructured":"Lei, C., Yang, J., Hu, J. & Sun, X. On the calculation of TCID50 for quantitation of virus infectivity. Virol. Sin. 36, 141\u2013144. https:\/\/doi.org\/10.1007\/s12250-020-00230-5 (2021).","journal-title":"Virol. Sin."},{"key":"4246_CR36","doi-asserted-by":"publisher","unstructured":"Basak, P., Sachdeva, N. & Dayal, D. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis? Bioessays 43 (e2000200). https:\/\/doi.org\/10.1002\/bies.202000200 (2021).","DOI":"10.1002\/bies.202000200"},{"key":"4246_CR37","doi-asserted-by":"publisher","unstructured":"Singh, A. K. et al. Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation. bioRxiv (2022). https:\/\/doi.org\/10.1101\/2022.03.15.484018","DOI":"10.1101\/2022.03.15.484018"},{"key":"4246_CR38","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"S Moorlag","year":"2019","unstructured":"Moorlag, S., Arts, R. J. W., van Crevel, R. & Netea, M. G. Non-specific effects of BCG vaccine on viral infections. Clin. Microbiol. Infect. 25, 1473\u20131478. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.020 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"4246_CR39","doi-asserted-by":"publisher","unstructured":"Singh, A. K., Netea, M. G. & Bishai, W. R. BCG turns 100: its nontraditional uses against viruses, cancer, and Immunologic diseases. J. Clin. Invest. 131 https:\/\/doi.org\/10.1172\/jci148291 (2021).","DOI":"10.1172\/jci148291"},{"key":"4246_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158. https:\/\/doi.org\/10.1159\/000355628 (2014).","journal-title":"J. Innate Immun."},{"key":"4246_CR41","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1128\/iai.00279-12","volume":"80","author":"WJ Chua","year":"2012","unstructured":"Chua, W. J. et al. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect. Immun. 80, 3256\u20133267. https:\/\/doi.org\/10.1128\/iai.00279-12 (2012).","journal-title":"Infect. Immun."},{"key":"4246_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/imcb.12007","volume":"96","author":"P Steigler","year":"2018","unstructured":"Steigler, P. et al. BCG vaccination drives accumulation and effector function of innate lymphoid cells in murine lungs. Immunol. Cell. Biol. 96, 379\u2013389. https:\/\/doi.org\/10.1111\/imcb.12007 (2018).","journal-title":"Immunol. Cell. Biol."},{"key":"4246_CR43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic, B. et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell. Host Microbe. 28, 322\u2013334e325. https:\/\/doi.org\/10.1016\/j.chom.2020.05.014 (2020).","journal-title":"Cell. Host Microbe"},{"key":"4246_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176\u2013190e119. https:\/\/doi.org\/10.1016\/j.cell.2017.12.031 (2018).","journal-title":"Cell"},{"key":"4246_CR45","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ijo.2014.41","volume":"38","author":"HN Na","year":"2014","unstructured":"Na, H. N. & Nam, J. H. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Int. J. Obes. (Lond). 38, 1470\u20131474. https:\/\/doi.org\/10.1038\/ijo.2014.41 (2014).","journal-title":"Int. J. Obes. (Lond)"},{"key":"4246_CR46","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","volume":"10","author":"C Covi\u00e1n","year":"2019","unstructured":"Covi\u00e1n, C. et al. BCG-Induced Cross-Protection and development of trained immunity: implication for vaccine design. Front. Immunol. 10, 2806. https:\/\/doi.org\/10.3389\/fimmu.2019.02806 (2019).","journal-title":"Front. Immunol."},{"key":"4246_CR47","doi-asserted-by":"publisher","first-page":"29242","DOI":"10.1038\/s41598-024-78922-1","volume":"14","author":"N Namdar","year":"2024","unstructured":"Namdar, N., Fasaei, N., Shariati, B., Joghataei, P., Arpanaei, A. & S. M. & Mesoporous silica nanoparticles co-loaded with lysozyme and Vancomycin for synergistic antimicrobial action. Sci. Rep. 14, 29242. https:\/\/doi.org\/10.1038\/s41598-024-78922-1 (2024).","journal-title":"Sci. Rep."},{"key":"4246_CR48","doi-asserted-by":"publisher","first-page":"1232764","DOI":"10.3389\/fimmu.2023.1232764","volume":"14","author":"KL Hilligan","year":"2023","unstructured":"Hilligan, K. L., Namasivayam, S. & Sher, A. BCG mediated protection of the lung against experimental SARS-CoV-2 infection. Front. Immunol. 14, 1232764. https:\/\/doi.org\/10.3389\/fimmu.2023.1232764 (2023).","journal-title":"Front. Immunol."},{"key":"4246_CR49","doi-asserted-by":"publisher","first-page":"801799","DOI":"10.3389\/fimmu.2021.801799","volume":"12","author":"AD White","year":"2021","unstructured":"White, A. D. et al. Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in Rhesus macaques. Front. Immunol. 12, 801799. https:\/\/doi.org\/10.3389\/fimmu.2021.801799 (2021).","journal-title":"Front. Immunol."},{"key":"4246_CR50","doi-asserted-by":"publisher","first-page":"107733","DOI":"10.1016\/j.isci.2023.107733","volume":"26","author":"AK Singh","year":"2023","unstructured":"Singh, A. K. et al. Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells. iScience 26, 107733. https:\/\/doi.org\/10.1016\/j.isci.2023.107733 (2023).","journal-title":"iScience"},{"key":"4246_CR51","doi-asserted-by":"publisher","first-page":"e45638","DOI":"10.7759\/cureus.45638","volume":"15","author":"S Ravichandran","year":"2023","unstructured":"Ravichandran, S., Vijayakumar, K., P, M. S. & G, V. V. & Vaccination can prevent severe pulmonary disease in COVID-19 positive patients: A Case-Control study. Cureus 15, e45638. https:\/\/doi.org\/10.7759\/cureus.45638 (2023).","journal-title":"Cureus"},{"key":"4246_CR52","doi-asserted-by":"publisher","unstructured":"Hilligan, K. L. et al. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. J. Exp. Med. 219 https:\/\/doi.org\/10.1084\/jem.20211862 (2022).","DOI":"10.1084\/jem.20211862"},{"key":"4246_CR53","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3389\/fimmu.2018.02439","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Heterologous boost following Mycobacterium bovis BCG reduces the late persistent, rather than the early stage of intranasal tuberculosis challenge infection. Front. Immunol. 9, 2439. https:\/\/doi.org\/10.3389\/fimmu.2018.02439 (2018).","journal-title":"Front. Immunol."},{"key":"4246_CR54","doi-asserted-by":"publisher","first-page":"63804","DOI":"10.18632\/oncotarget.11542","volume":"7","author":"J Ma","year":"2016","unstructured":"Ma, J. et al. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity. Oncotarget 7, 63804\u201363815. https:\/\/doi.org\/10.18632\/oncotarget.11542 (2016).","journal-title":"Oncotarget"},{"key":"4246_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.53350\/pjmhs2216591","volume":"16","author":"M Umer","year":"2022","unstructured":"Umer, M., Shabbir, F. & Siddiqui, A. A. Efficacy of high and low dose of BCG and their complications in superficial transtional cell carcinoma of urinary bladder. Pakistan J. Med. Health Sci. 16, 91\u201391. https:\/\/doi.org\/10.53350\/pjmhs2216591 (2022).","journal-title":"Pakistan J. Med. Health Sci."},{"key":"4246_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12917-024-04395-z","volume":"20","author":"H Esmaeili","year":"2024","unstructured":"Esmaeili, H., Ghorani, M., Joghataei, S. M., Villanueva-Saz, S. & Lacasta, D. Live attenuated goatpox vaccination in pregnant Murcia-Granada goats: dosage implications and outcomes. BMC Vet. Res. 20, 544. https:\/\/doi.org\/10.1186\/s12917-024-04395-z (2024).","journal-title":"BMC Vet. Res."},{"key":"4246_CR57","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/infdis\/jiab593","volume":"225","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 vaccines. J. Infect. Dis. 225, 1141\u20131150. https:\/\/doi.org\/10.1093\/infdis\/jiab593 (2022).","journal-title":"J. Infect. Dis."},{"key":"4246_CR58","doi-asserted-by":"publisher","first-page":"23308","DOI":"10.1038\/s41598-021-02442-5","volume":"11","author":"B Khatri","year":"2021","unstructured":"Khatri, B. et al. Efficacy and immunogenicity of different BCG doses in BALB\/c and CB6F1 mice when challenged with H37Rv or Beijing HN878. Sci. Rep. 11, 23308. https:\/\/doi.org\/10.1038\/s41598-021-02442-5 (2021).","journal-title":"Sci. Rep."},{"key":"4246_CR59","doi-asserted-by":"publisher","first-page":"e13342","DOI":"10.1111\/sji.13342","volume":"99","author":"V Krmesk\u00e1","year":"2024","unstructured":"Krmesk\u00e1, V., Shen, L., Nyl\u00e9n, S., Wowk, P. F. & Rothfuchs, A. G. BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node. Scand. J. Immunol. 99, e13342. https:\/\/doi.org\/10.1111\/sji.13342 (2024).","journal-title":"Scand. J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04246-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:57:46Z","timestamp":1765969066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4246"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04246-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The Acknowledgements section in the original version of this Article was incomplete. It now reads: \u201cThe authors would like to express their sincere gratitude to the Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran and Center for International Scientific Studies and Collaboration (Grant No. 4020472) for their valuable support and resources throughout the study. Special thanks are extended to the Razi Vaccine and Serum Research Institute (RVSRI) in Iran for pro\u00adviding critical materials and technical assistance. The authors also acknowledge the contributions of the Scion Research Institute in New Zealand for their collaboration and guidance in ensuring the successful completion of this research.\"","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18908"}}